Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADCY1 | Q08828 | 17/20 | 0.73 |
| ▸ | ADCY8 | P40145 | 16/20 | 0.73 |
| ▸ | SLC2A1 | P11166 | 2/20 | 0.61 |
| ▸ | HTR2B | P41595 | 3/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23249757 | 0.86 | SLC2A1 (0.62) | ADCY1ADCY8SLC2A1HTR2B | |
| SCHEMBL23249629 | 0.85 | SLC2A1 (0.66) | ADCY1ADCY8SLC2A1HTR2B | |
| SCHEMBL23249651 | 0.85 | SLC2A1 (0.59) | ADCY1ADCY8SLC2A1HTR2B | |
| SCHEMBL23259411 | 0.85 | SLC2A1 (0.59) | ADCY1ADCY8SLC2A1HTR2B | |
| SCHEMBL23249509 | 0.85 | ADCY8 (0.53) | ADCY1ADCY8SLC2A1HTR2B | |
| SCHEMBL20673031 | 0.84 | ADCY1 (1.00) | ADCY1ADCY8HTR2B | |
| SCHEMBL20657978 | 0.84 | ADCY1 (0.74) | ADCY1ADCY8HTR2B | |
| SCHEMBL20673074 | 0.84 | ADCY1 (0.72) | ADCY1ADCY8SLC2A1HTR2B | |
| SCHEMBL20673018 | 0.84 | ADCY1 (0.71) | ADCY1ADCY8SLC2A1HTR2B | |
| SCHEMBL23249615 | 0.82 | SLC2A1 (0.77) | ADCY1ADCY8SLC2A1HTR2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240139190-A1 | NOVEL ANTIPARASITIC COMPOUNDS AND METHODS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | 2024-05-02 | — | — | US | disclosed |
| WO-2021077102-A1 | NOVEL ANTIPARASITIC COMPOUNDS AND METHODS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2021-04-22 | — | — | WO | disclosed |
| WO-2021077102-A1 | NOVEL ANTIPARASITIC COMPOUNDS AND METHODS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2021-04-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240139190-A1 | NOVEL ANTIPARASITIC COMPOUNDS AND METHODS | TUBB, TUBB1, TUBA1C | ADCY1 4578/4885ADCY8 4219/4885SLC2A1 4433/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.